Consulting Agreements: Dos and Don’ts | Coffee Break Life Sciences Start-ups #6

Coffee Break Life Sciences | Overview page

Navigating the revised EU Urban Wastewater Treatment Directive | Coffee Break Life Sciences #1

17. Januar 2025

von Dr. Kris Breudel, LL.M. (Aberdeen)

Regulatory Peculiarities |Coffee Break Life Sciences Start Ups #12

20. Dezember 2024

Website, Social Media, Advertising & Co. | Coffee Break Life Sciences Start-ups #11

19. November 2024

Think big – possible exit strategies | Coffee Break Life Sciences Start-ups #10

20. Oktober 2024

von Alisa Mathes-Salathe

Data Protection for Life Sciences start-ups, particularly in connection with clinical trials | Coffee Break Life Sciences Start-ups #9

27. September 2024

von Dr. Tim Schwarz, Phillip Heske

Clinical trials in the medical devices area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #8

22. August 2024

Clinical trials in the pharmaceutical area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #7

18. Juli 2024

von Irina Rebin

Consulting Agreements: Dos and Don’ts | Coffee Break Life Sciences Start-ups #6

26. Juni 2024

Employment Law in a Nutshell | Coffee Break Life Sciences Start-ups #5

15. Mai 2024

von Dr. Jan W. Grawe

R&D Collaborations | Coffee Break Life Sciences Start-ups #4

18. April 2024

von Irina Rebin

Tips and tricks for your financing round | Coffee Break Life Sciences Start-ups #3

20. März 2024

von Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2

23. Februar 2024

Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1

30. Januar 2024